Blindness in Germany: Dimensions and perspectives;Blindheit in Deutschland: Dimensionen und Perspektiven

Ophthalmologe

Volumn 104, Issue 10, 2007, Pages 839-844

  Finger, R P ^a,b  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b CURTIN UNIVERSITY   (Australia)

Author keywords

Blindness; Germany; Prevention; Rehabilitation; Visual impairment

Indexed keywords

EID: 35948958195     PISSN: 0941293X     EISSN: 14330423     Source Type: Journal    
DOI: 10.1007/s00347-007-1600-3     Document Type: Article

References (34)

1. Barry RJ, Murray PI (2005) Unregistered visual impairment: is registration a failing system? Br J Ophthalmol 89: 995-998
2. Brezin AP, Lafuma A, Fagnani F et al. (2004) Blindness, low vision, and other handicaps as risk factors attached to institutional residence. Br J Ophthalmol 88: 1330-1337
3. Brezin AP, Lafuma A, Fagnani F et al. (2005) Prevalence and burden of self-reported blindness and low vision for individuals living in institutions: a nationwide survey. Health Qual Life Outcomes 3: 27
4. Brezin AP, Lafuma A, Fagnani F et al. (2005) Prevalence and burden of self-reported blindness, low vision, and visual impairment in the French community: a nationwide survey. Arch Ophthalmol 123: 1117-1124
5. Brody BL, Roch-Levecq AC, Gamst AC et al. (2002) Self-management of age-related macular degeneration and quality of life: a randomized controlled trial. Arch Ophthalmol 120: 1477-1483
6. Brody BL, Roch-Levecq AC, Thomas RG et al. (2005) Self-management of age-related macular degeneration at the 6-month follow-up: a randomized controlled trial. Arch Ophthalmol 123: 46-53
7. Bunce C, Wormald R (2007) Causes of blind certifications in England and Wales: April 1999-March 2000. Eye
8. Bundesärztekammer (2006) Einführung der Disease Management Programme (DMP
9. Campbell AJ, Robertson MC, La Grow SJ et al. (2005) Randomised controlled trial of prevention of falls in people aged > 75 with severe visual impairment: the VIP trial. BMJ 331: 817
10. Casten RJ, Rovner BW, Tasman W (2004) Age-related macular degeneration and depression: a review of recent research. Curr Opin Ophthalmol 15: 181-183
11. Crews JE, Campbell VA (2004) Vision impairment and hearing loss among community-dwelling older Americans: implications for health and functioning. Am J Public Health 94: 823-829
12. Deutscher Blinden- und Sehbehindertenverband (DBSV) (2007) Infothek - Empfänger von Blindengeld
13. Espinet LM, Osmick MJ, Ahmed T, Villagra VG (2005) A cohort study of the impact of a national disease management program on HEDIS diabetes outcomes. Dis Manag 8: 86-92
14. Graf M, Halbach E, Kaufmann H (1999) Causes of blindness in Hessia in 1996. Klin Monatsbl Augenheilkd 215: 50-55
15. Hirneiss C, Neubauer AS, Tribus C, Kampik A (2006) Value-based medicine in ophthalmology. Ophthalmologe
16. Klaver CC, Wolfs RC, Vingerling JR et al. (1998) Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol 116: 653-658
17. Knauer C, Pfeiffer N (2006) Blindness in Germany - today and in 2030. Ophthalmologe 103: 735-741
18. Krumpaszky HG, Klauss V, Kloske G (1992) Social costs of visual handicap and blindness. Rehabilitation resources for blind patients. Klin Monatsbl Augenheilkd 201: 370-374
19. Lafuma A, Brezin A, Lopatriello S et al. (2006) Evaluation of non-medical costs associated with visual impairment in four European countries: France, Italy, Germany and the UK. Pharmacoeconomics 24: 193-205
20. Legood R, Scuffham P, Cryer C (2002) Are we blind to injuries in the visually impaired? A review of the literature. Inj Prev 8: 155-160
21. Mitchell J, Bradley C (2006) Quality of life in age-related macular degeneration: a review of the literature. Health Qual Life Outcomes 4: 97
22. Pascolini D, Mariotti SP, Pokharel GP et al. (2004) 2002 global update of available data on visual impairment: a compilation of population-based prevalence studies. Ophthalmic Epidemiol 11: 67-115
23. Pfau N, Kupsch S, Kern AO, Beske F (2000) Epidemiologie und sozioökonomische Bedeutung von Blindheit und hochgradiger Sehbehinderung in Deutschland. Institut für Gesundheits- und Sozialforschung GmbH (IGSF) Schriftenreihe, Kiel
24. Resnikoff S, Pascolini D, Etya'ale D et al. (2004) Global data on visual impairment in the year 2002. Bull World Health Organ 82: 844-851
25. Rinnert T, Lindner H, Behrens-Baumann W (1999) At home utilization of low-vision aids by the visually impaired. Klin Monatsbl Augenheilkd 215: 305-310
26. Sadowski B, Grub A, Trauzettel-Klosinski S (2000) Reading ability and need for reading aids, inadequate management of a nursing home population. Klin Monatsbl Augenheilkd 217: 278-283
27. Schrader WF (2006) [Age-related macular degeneration: a socioeconomic time bomb in our aging society]. Ophthalmologe 103: 742-748
28. Statistisches Bundesamt Deutschland (2007) Gesundheitsberichterstattung des Bundes
29. Statistisches Bundesamt Deutschland (2007) Statistik der Schwerbehinderten Menschen 2005 Kurzbericht. In: Statistisches Bundesamt, Wiesbaden
30. Trautner C, Haastert B, Giani G, Berger M (2001) Incidence of blindness in southern Germany between 1990 and 1998. Diabetologia 44: 147-150
31. Trautner C, Haastert B, Richter B et al. (2003) Incidence of blindness in southern Germany due to glaucoma and degenerative conditions. Invest Ophthalmol Vis Sci 44: 1031-1034
32. Varma R, Wu J, Chong K et al. (2006) Impact of severity and bilaterality of visual impairment on health-related quality of life. Ophthalmology 113: 1846-1853
33. Villagra VG, Ahmed T (2004) Effectiveness of a disease management program for patients with diabetes. Health Aff (Millwood) 23: 255-266
34. Williams RA, Brody BL, Thomas RG et al. (1998) The psychosocial impact of macular degeneration. Arch Ophthalmol 116: 514-520